上海阿拉丁生化科技股份有限公司 公司信息
公司名称:
上海阿拉丁生化科技股份有限公司
电话:
400-6206333
电子邮件:
anhua.mao@aladdin-e.com
国籍:
中国
网址:
www.aladdin-e.com/
产品总数:
48457
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
公司提供产品列表
Brentuximab (anti-TNFRSF8)
2088770-90-3
Motavizumab (anti-RSV-F)
677010-34-3
Zanamivir
扎那米韦
139110-80-8
Zandelisib
1401436-95-0
Farletuzumab (anti-FOLR1)
896723-44-7
Blosozumab (anti-SOST)
1132758-87-2
Aprutumab (anti-FGFR2)
1634620-63-5
Etokimab (anti-IL-33)
2022981-44-6
Zileuton (A-64077)
111406-87-2
Omalizumab (anti-IgE)
242138-07-4
Tregalizumab (anti-CD4)
1207446-68-1
Fletikumab (anti-IL-20)
1357158-22-5
Abituzumab (anti-ITGAV)
1105038-73-0
Tiragolumab (anti-TIGIT)
1918185-84-8
Belantamab (anti-TNFRSF17)
2061894-48-0
Mupadolimab (anti-CD73)
2451856-97-4
Mepolizumab (anti-IL-5)
196078-29-2
Lorvotuzumab (anti-CD56)
339306-30-8
Zoledronic Acid Disodium Salt Tetrahydrate
唑来膦酸二钠盐四水合物
165800-07-7
Zinc acetylacetonate hydrate
乙酰丙酮锌 水合物
108503-47-5
Zalcitabine
2',3'-二脱氧胞苷
7481-89-2
Canakinumab (Anti-IL-1b)
914613-48-2
Sifalimumab (anti-IFNa1)
1006877-41-3
Onartuzumab (anti-MET)
1133766-06-9
Anifrolumab (anti-IFNAR1)
1326232-46-5
Rovalpituzumab (anti-DLL3)
1613313-01-1
Omburtamab (anti-CD276)
1895083-75-6
Nadunolimab (anti-IL-1 RAcP)
2171061-85-9
Zolantidine dimaleate
Zolantidine 二马来酸盐
104076-39-3
Zibotentan (ZD4054)
186497-07-4
Necitumumab (anti-EGFR)
906805-06-9
Zolmitriptan
佐米曲坦
139264-17-8
Zirconium acetate
乙酸锆
7585-20-8
Zirconium hydroxide
氢氧化锆
14475-63-9
Recombinant Human VEGF Protein
127464-60-2
Z-LEHD-FMK TFA
524746-03-0
Figitumumab (anti-IGF1R)
943453-46-1
Naxitamab (anti-GD2)
1879925-92-4
ZM 306416
ZM 306416, VEGFR 的有效抑制剂
690206-97-4
Zilovertamab (anti-ROR1)
2485779-13-1
Zearalenone from Giberella zeae
玉米烯酮 来源于赤霉菌
17924-92-4
Tremelimumab (anti-CTLA-4)
745013-59-6
Zaltoprofen
扎托布洛芬
74711-43-6
Zoledronic Acid
118072-93-8
Zebularine (NSC 309132)
泽布拉林
3690-10-6
Amatuximab (anti-MSLN)
931402-35-6
Mavrilimumab (anti-CD116)
1085337-57-0
Olokizumab (anti-IL-6)
1007223-17-7
Pamrevlumab (anti-CTGF)
946415-13-0
Selicrelumab (anti-CD40)
1622140-49-1
Spartalizumab (anti-PD-1)
1935694-88-4
Envafolimab (anti-PD-L1)
2102192-68-5
Vibostolimab (anti-TIGIT)
2231305-30-7
Teplizumab (anti-CD3e)
876387-05-2
Sotigalimab (anti-CD40)
2305607-45-6
Cusatuzumab (anti-CD70)
1864871-20-4
Vedolizumab (anti-α4β7-integrin)
943609-66-3
Fezakinumab (anti-IL-22)
1007106-86-6
Etrolizumab (anti-α4β7)
1044758-60-2
Simtuzumab (anti-LOXL2)
1318075-13-6
Emapalumab (anti-IFNγ)
1709815-23-5
Relatlimab (anti-LAG-3/CD223)
1673516-98-7
Onvatilimab (anti-VISTA)
1969313-51-6
Penpulimab (anti-PDCD1)
2350298-92-7
ZM 39923 HCl
1021868-92-7
Aducanumab (anti-APP)
1384260-65-4
Zinc Pyrithione
2-巯基吡啶-N-氧化物 锌盐
13463-41-7
Ibalizumab (anti-CD4)
680188-33-4
Bemarituzumab (anti-FGFR2)
1952272-74-0
Sabatolimab (anti-TIM-3)
2252262-24-9
Zinc iron oxide
纳米铁酸锌
12063-19-3
Evolocumab(anti-PCSK9)
1256937-27-5
Patritumab (anti-ERBB3)
1262787-83-6
Otelixizumab (anti-CD3)
881191-44-2
Teprotumumab (anti-IGF1R)
1036734-93-6
Evinacumab (anti-ANGPTL3)
1446419-85-7
Oleclumab (anti-CD73)
1803176-05-7
Magrolimab (anti-CD47)
2169232-81-7
Panitumumab (anti-EGFR)
339177-26-3
Muromonab (anti-CD3)
140608-64-6
Denosumab (anti-TNFSF11)
615258-40-7
Eptinezumab (anti-CGRP)
1644539-04-7
Varlilumab (anti-TNFRSF7)
1393344-72-3
Zinc fluoborate hydrate
四氟硼酸锌 水合物
27860-83-9
Zafirlukast (ICI-204219)
扎鲁斯特
107753-78-6
Mirvetuximab (anti-FOLR1)
1453084-36-0
Sacituzumab (anti-TROP2)
1796566-95-4
Zinc selenide
硒化锌
1315-09-9
Sofituzumab (anti-MUC16)
1615692-28-8
Ofatumumab (anti-CD20)
679818-59-8
Emicizumab (anti-Factor IX)
1610943-06-0
Brodalumab (anti-IL17RA)
1174395-19-7
Risankizumab (anti-IL-23)
1612838-76-2
Z-FA-FMK
197855-65-5
Siltuximab (anti-IL-6)
541502-14-1
Margetuximab (anti-HER2)
1350624-75-7
Isatuximab (anti-CD38)
1461640-62-9
Erenumab (anti-CALCRL)
1582205-90-0
Sintilimab (anti-PD-1)
2072873-06-2
Talquetamab (anti-GPRC5D)
2226212-40-2
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
Copyright 2007© ChemicalBook. All rights reserved.